18F-FDG PET for assessment of therapy response and preoperative re-evaluation after neoadjuvant radio-chemotherapy in stage III non-small cell lung cancer

Susanne Martina Eschmann; Godehard Friedel; Frank Paulsen; Matthias Reimold; Thomas Hehr; Wilfried Budach; Heinz-Jakob Langen; Roland Bares

首页> 外文期刊>European Journal of Nuclear Medicine and Molecular Imaging >18F-FDG PET for assessment of therapy response and preoperative re-evaluation after neoadjuvant radio-chemotherapy in stage III non-small cell lung cancer

【24h】

18F-FDG PET for assessment of therapy response and preoperative re-evaluation after neoadjuvant radio-chemotherapy in stage III non-small cell lung cancer

机译：18 F-FDG PET评估III期非小细胞肺癌新辅助放化疗后的治疗反应和术前重新评估

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

The aim of this study was to evaluate FDG-PET for assessment of therapy response and for prediction of patient outcome after neo-adjuvant radio-chemotherapy (NARCT) of advanced non-small cell lung cancer (NSCLC).

机译：这项研究的目的是评估FDG-PET，以评估晚期非小细胞肺癌（NSCLC）的新辅助放化疗（NARCT）后的治疗反应和预测患者的预后。

著录项

来源
《European Journal of Nuclear Medicine and Molecular Imaging》 |2007年第4期|463-471|共9页
作者
Susanne Martina Eschmann; Godehard Friedel; Frank Paulsen; Matthias Reimold; Thomas Hehr; Wilfried Budach; Heinz-Jakob Langen; Roland Bares;
展开▼
作者单位

Department of Nuclear Medicine University of Tübingen Otfried-Mueller-Strasse 14 72076 Tübingen Germany;

Department of Thoracic Surgery Schillerhöhe Hospital for Lung Diseases Gerlingen Germany;

Department of Radiation Oncology University of Tübingen Tübingen Germany;

Department of Nuclear Medicine University of Tübingen Otfried-Mueller-Strasse 14 72076 Tübingen Germany;

Department of Radiation Oncology University of Tübingen Tübingen Germany;

Department of Radiation Oncology University of Düsseldorf Düsseldorf Germany;

Department of Radiology Medical Mission Hospital Würzburg Würzburg Germany;

Department of Nuclear Medicine University of Tübingen Otfried-Mueller-Strasse 14 72076 Tübingen Germany;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词
Non-small cell lung cancer; FDG-PET; Treatment response; Restaging; Radio-chemotherapy;

机译：非小细胞肺癌;FDG-PET;治疗反应;分期;放化疗;

相似文献

外文文献
中文文献
专利

1. 18F-FDG PET for assessment of therapy response and preoperative re-evaluation after neoadjuvant radio-chemotherapy in stage III non-small cell lung cancer. [J] . Eschmann SM, Friedel G, Paulsen F, European Journal of Nuclear Medicine and Molecular Imaging . 2007,第4期

机译：18F-FDG PET用于评估III期非小细胞肺癌新辅助放化疗后的治疗反应和术前重新评估。
2. Repeat 18F-FDG PET for monitoring neoadjuvant chemotherapy in patients with stage III non-small cell lung cancer. [J] . Eschmann SM, Friedel G, Paulsen F, Lung cancer: Journal of the International Association for the Study of Lung Cancer . 2007,第2期

机译：重复18F-FDG PET监测III期非小细胞肺癌患者的新辅助化疗。
3. Response assessment using 18F-FDG PET early in the course of radiotherapy correlates with survival in advanced-stage non-small cell lung cancer [J] . VanElmptW., Ol?lersM., DingemansA.-M.C., The Journal of Nuclear Medicine . 2012,第10期

机译：在放疗早期使用18F-FDG PET进行的反应评估与晚期非小细胞肺癌的生存率相关
4. Early Assessment of the Added Value of FDG-PET/CT and MRI-DWI in Monitoring Treatment Response of Stage III Non-Small Cell Lung Cancer [C] . K.R. Siegersma, J.M. Hummel, H. Broekhuizen Mediterranean Conference on Medical and Biological Engineering and Computin . 2016

机译：早期评估FDG-PET / CT和MRI-DWI的增加值监测III期非小细胞肺癌的治疗响应
5. A Study of Erlotinib Monotherapy and in Combination with Pembrolizumab in Previously Untreated Stage I-IIIA Non-small Cell Lung Cancer [D] . Liu, Qiong. 2021

机译：Erlotinib单疗法和蛋白质在先前未处理阶段I-IIIA非小细胞肺癌中的研究
6. Response assessment using 18F-FDG PET early in the course of chemo-radiotherapy is correlated with survival in advanced stage non-small cell lung cancer [O] . Wouter van Elmpt, Michel Öllers, Anne-Marie C. Dingemans, -1

机译：在化学放疗的早期使用18F-FDG PET进行的反应评估与晚期非小细胞肺癌的生存率相关
7. Anti-cytokeratin CAM5.2 Recognized CK8 Mainly, but not CK18: Comment on “Early Assessment of Axillary Response with 18F-FDG PET/CT During Neoadjuvant Chemotherapy in Stage II–III Breast Cancer: Implications for Surgical Management of the Axilla. Annals of Surgical Oncology doi: 10.1245/s10434-013-2902-0 (2013)” [O] . Wan-Ru Chao, Chih-Ping Han 2013

机译：反科学研究CAM5.2主要识别CK8，但不是CK18：评论“在III阶段乳腺癌中新辅助化疗期间与18F-FDG PET / CT的腋窝响应的早期评估：对腋窝手术管理的影响。外科肿瘤学NOI：10.1245 / S10434-013-2902-0（2013）“

18F-FDG PET for assessment of therapy response and preoperative re-evaluation after neoadjuvant radio-chemotherapy in stage III non-small cell lung cancer

摘要

著录项

相似文献

相关主题

期刊订阅